Rinaldi, M <br/><br/>
Clinical end points for the assessment of cytostatic agents.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Oct 2002 
 - S37 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(02)00251-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--analysis<br/>Clinical Trials as Topic<br/>Endpoint Determination<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Prognosis<br/>Research Design<br/>Survival